Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 708,810 | 1,008,680 | 1,552,802 | 2,443,430 | 0 |
| Marketable Securities | 1,138,174 | 1,053,263 | 623,034 | 372,179 | 0 |
| Receivables | 39,995 | 39,166 | 36,761 | 35,454 | 0 |
| Other current assets | 529,045 | 595,789 | 571,254 | 539,726 | 0 |
| TOTAL | $2,416,024 | $2,696,898 | $2,783,851 | $3,390,789 | $0 |
| Non-Current Assets | |||||
| PPE Net | 12,599,080 | 12,368,080 | 11,927,580 | 11,169,860 | N/A |
| Investments And Advances | 871,733 | 916,641 | 1,239,898 | 1,084,652 | 0 |
| Intangibles | 22,995 | 28,666 | 34,462 | 40,258 | 0 |
| Other Non-Current Assets | 4,252 | 10,003 | 4,890 | 0 | 0 |
| TOTAL | $13,498,060 | $13,323,390 | $13,206,830 | $12,294,770 | $N/A |
| Total Assets | $15,914,090 | $16,020,290 | $15,990,680 | $15,685,560 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 182,226 | 0 |
| Accounts payable and accrued liabilities | 135,712 | 155,741 | 159,983 | 157,137 | 0 |
| Accrued Expenses | 120,271 | 152,146 | 110,000 | 111,610 | 0 |
| TOTAL | $255,983 | $307,887 | $269,983 | $450,973 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,821,072 | 5,816,584 | 5,812,047 | 5,729,622 | 0 |
| Other Non-Current Liabilities | -89,860 | -195,534 | -223,622 | -49,902 | -37,856 |
| TOTAL | $5,821,072 | $5,816,584 | $5,922,047 | $5,839,622 | $N/A |
| Total Liabilities | $6,077,055 | $6,124,471 | $6,192,030 | $6,290,595 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 607,113 | 607,111 | 388,132 | 365,899 | N/A |
| Common Shares | 102 | 102 | 100 | 100 | 0 |
| Retained earnings | 1,923,771 | 1,920,635 | 1,807,146 | 1,571,399 | 0 |
| Other shareholders' equity | 4,983,911 | 5,111,114 | 5,381,426 | 5,268,225 | 0 |
| TOTAL | $9,837,033 | $9,895,815 | $9,798,648 | $9,394,961 | $0 |
| Total Liabilities And Equity | $15,914,088 | $16,020,286 | $15,990,678 | $15,685,556 | $0 |